AKEBIA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.21 USD | -9.02% |
|
-11.68% | -2.42% |
| May. 09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| May. 09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Bio Therapeutic Drugs | -9.02% | -11.68% | -2.42% | +17.48% | -79.77% | 253M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- AKBA Stock
- Charts Akebia Therapeutics, Inc.
- Comparison Chart